Discover how gross profit and operating income differ and why both are crucial in assessing a company’s financial health. Get ...
Learn the critical differences between revenue and income, their impact on financial health, and how understanding each can ...
Non-GAAP operating income was $323 million, with a non-GAAP operating margin of 12.7%, a sequential increase of 40 basis points. Adjusted EBITDA reached $379 million (14.8% margin), while non-GAAP net ...
Rojansky announced, "We are increasing the revenue midpoint by 2% and the adjusted operating income midpoint by 11%. Our full year outlook is based on EyeQ volumes of 35 million to 35.5 million, up ...
Amdocs (NASDAQ: DOX) and CSG Systems (NASDAQ: CSGS) both serve the telecom software market, but their recent earnings show two companies executing very different playbooks. Amdocs posted Q4 2025 ...
Netflix reported generally positive results for first-quarter 2025, with revenue up 13% year-over-year to $10.543 billion and operating income growing by 27% to $3.347 billion. Both were ahead of the ...
*Includes aircraft rental payments of $301 million and $284 million for the six months ended June 30, 2025, and 2024, respectively. This article was originally published on Quiver News, read the full ...
(1) These amounts include restricted cash of $7.5 and $7.3 as of February 28, 2025 and February 23, 2024, respectively. (2) These amounts include restricted cash of $6.6 and $7.1 as of May 30, 2025 ...
New Hyde Park, N.Y.-based Northwell Health recorded an operating income of $291.9 million (1.6% operating margin) in 2024, up from an operating income of $197.7 million (1.2% margin) in 2023, ...
As AI adoption accelerates, costs and margins are becoming highly variable. Usage now fluctuates in real time based on inference volume, model choice, and automated workflows. For many, this has ...
Groww reported an operating revenue of Rs 1,216 crore in the December quarter, up 24.8% from Rs 974 crore a year back. The ...
Fresenius Medical Care, the world's leading provider of products and services for individuals with renal disease, continued to advance the FME Reignite strategy. During the third quarter of 2025, the ...